CD8A and neoplasm: Tumors can also subvert immunity by regulating pDC production of IFN-α, a type I IFN that functions as a “signal 3” cytokine for CD8+ T cell activation (135) and that promotes the survival and Ag retention of CD8α+ DC that cross-prime tumor-specific CD8+ T cells (11).